Status:

COMPLETED

Nitrous Oxide Added at the End of Sevoflurane Anesthesia and Recovery

Lead Sponsor:

General Hospital Zadar

Conditions:

Elective Surgical Procedures

Laparoscopy

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

Addition of nitrous oxide N2O towards the end of prolonged isoflurane anesthesia hastens patients recovery. The hypothesis is that the addition of N2O at the end of prolonged sevoflurane anaesthesia a...

Detailed Description

The investigators will include 100 adult patients, American Society of Anesthesiologists (ASA) physical status I-III, who will be scheduled for elective laparotomies or laparoscopic surgeries under se...

Eligibility Criteria

Inclusion

  • Adult patients, American Society of Anesthesiologists Physical status ASA PS I-III, scheduled for laparotomic and laparoscopic surgery expected to last 2 hours or more who can understand and signed informed consent.

Exclusion

  • Patients who will be discharged within 72 hours after surgery
  • Patients on intensive care within few months before the study enrollment
  • Diseases that impair gastric motility (diabetes mellitus, chronic cholecystitis, gastric and intestinal disease, neuromuscular disorders, neuropathies, liver dysfunction)
  • Vestibular disease; history of migraine headaches, central nervous system injury
  • Renal impairment
  • Patients on antihistamines, antipsychotics, contraceptives, steroids within 72 hours before surgery
  • Known hypersensitivity to drugs used in the study protocol
  • Alcoholism, and/or opioid addiction
  • Conditions that can influence the incidence of PONV, postoperative pain or morbidity (e.g., significant intraoperative surgery complications), intraoperative drug allergy, severe intraoperative hypotension, perioperative hypoxia, excessive blood loss, difficult intubation

Key Trial Info

Start Date :

February 7 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 25 2021

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03420586

Start Date

February 7 2018

End Date

July 25 2021

Last Update

November 9 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

General Hospital Zadar

Zadar, Croatia, 23000